Middle East and Africa Kidney Cancer Diagnostics Market is expected to reach a value of USD 896.76 million by 2030

PRESS RELEASE
Published November 6, 2023

Middle East and Africa Kidney Cancer Diagnostics Market report assists in identifying new market opportunities for existing and new products. It provides information on market share, nature of competition, customer satisfaction levels, sales performances and channel of distribution. All these elements help the firm in solving problems. When it comes to predicting consumer needs or conducting market segmentation in such wide markets, market research report does a great job. The marketing intelligence provided through the report not only helps in framing but also in implementing the market strategies. A first-rate Middle East and Africa Kidney Cancer Diagnostics Market report supports the business to stay relevant, anticipate change, as well as predict the change.

Kidney cancer begins when healthy cells in one or both kidneys change and grow uncontrollably, forming a mass called a cortical tumor. The tumor can be malignant, indolent or benign. Malignancy is cancer, which means it can grow and spread to other parts of the body. An indolent tumor is also cancer, but this type of tumor rarely spreads to other parts of the body. A benign tumor means that the tumor can grow but not spread.

Download the PDF Sample Report:  https://www.databridgemarketresearch.com/request-a-sample/?dbmr=middle-east-and-africa-kidney-cancer-diagnostics-market&Shri

The rising awareness about kidney cancer Middle East and Africa has enhanced the demand for the market. The rising healthcare expenditure for better health services also contributes to the market’s growth. The major market players focus on various service launches and approvals during this crucial period. In addition, the increase in improved diagnostic procedures for kidney cancer also contributes to the rising demand for kidney cancer diagnostics testing.

The Middle East and Africa kidney cancer diagnostics market is expected to grow in the forecast year due to the rise in market players and the availability of advanced services. Along with this, manufacturers are engaged in R&D activity for launching novel services in the market. The increasing research in the field of kidney diagnosis and development is expected to further boost the market growth. However, tissue damage due to high radiation exposure from imaging tests is expected to hamper the growth of the Middle East and Africa kidney cancer diagnostics market in the forecast period.

Data Bridge Market Research analyzes that the kidney cancer diagnostics market is expected to reach a value of USD 896.76 million by 2030, at a CAGR of 4.6% during the forecast period. Imaging accounts for the largest test type segment in the market due to rising demand for smart devices, and increasing health expenditure has accelerated the demand for smart medical devices.

Market Overview:

Kidney cancer, commonly known as renal cancer, is a condition in which kidney cells develop into malignant (cancerous) tumors and expand uncontrollably. One of the top 10 most prevalent cancers is kidney cancer. Kidney cancer is fatal, and the diagnosis process also has safety issues; it is not cost-effective. Cancer patients may be hospitalized and receive a variety of therapies, such as surgery, radiation therapy, and systemic therapy. About 40% of kidney growths are tiny, localized masses. Localized refers to a tumor that has not spread from its original location. Kidney masses cannot be detected with regular laboratory procedures. Diagnosis of kidney cancer includes biopsy procedures, blood tests, and Imaging tests. Advanced kidney cancer therapies, like immunotherapy, radiation therapy, etc., are advised. Due to cutting-edge methods, nonsurgical procedures like cryoablation (which freezes cancer cells) and radiofrequency ablation are sometimes used to treat minor kidney tumors (heat cancer cells).

Kidney cancer can be difficult to diagnose because, despite its wide range of signs and symptoms, they are non-specific and can be linked to other, more widespread medical conditions. More than 43,000 men and 25,000 women are diagnosed with kidney and renal pelvis cancer each year, and 9,000 men and 5,000 women pass away as a result of this illness. However, strict regulations and standards for the approval and commercialization of kidney cancer diagnostic products are expected to restrain market growth.

Recent Developments

  • In November 2022, Koninklijke Philips N.V. announced the Middle East and Africa launch of a next-generation compact portable ultrasound solution at the Radiological Society of North America (RSNA) annual meeting to bring the diagnostic quality associated with premium cart-based ultrasound systems to more patients. It is portable and versatile with good image quality or performance. It is Compatible with Philips ultrasound systems Affiniti and EPIQ transducer. This has helped the company to expand its product portfolio.
  • In October 2022, General Electric Company had collaborated with several research institutes like the University of Cambridge Hospitals, Sophia Genetics, and earlier with Optellum to use imaging data in collaboration with Artificial intelligence. This will help to reduce the diagnosing time of several cancers and help to provide personalized care to patients. This has helped the company to widen its horizons in cancer diagnostics.
  • In July 2022, Canon Medical Systems USA Inc. announced the completion of the acquisition of NXC Imaging, a medical imaging equipment distributor and service provider located in Minnesota, U.S. This results in expanding the service outreach in the Middle East and Africa market.

View the Comprehensive Report: https://www.databridgemarketresearch.com/reports/middle-east-and-africa-kidney-cancer-diagnostics-market?Shri

Some of the major players operating in the market are Siemens Healthcare GmbH, Koninklijke Philips N.V., FUJIFILM Corporation, Grail, Laboratory Corporation of America Holdings, Thermo Fisher Scientific, Myriad Genetics, Inc., CANON MEDICAL SYSTEMS CORPORATION, QIAGEN, Illumina Inc., Ambry Genetics, Invitae Corporation, General Electric Company, Centogene N.V., GenPath, Creative Diagnostics, GeneDx LLC, Blueprint Genetics Oy, BioVendor R&D, and CD Genomics, and BD, among others.

Middle East and Africa Kidney Cancer Diagnostics Market Scope

The Middle East and Africa kidney cancer diagnostics market is segmented into eight notable segments based on test type, cancer stage, tumor type, product, application, technology, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Test Type

  • IMAGING TEST
  • BIOMARKER TEST
  • BLOOD TEST
  • BIOPSY
  • GENETIC TEST
  • OTHERS

On the basis of test type, the Middle East and Africa kidney cancer diagnostics market is segmented into imaging, biomarker test, blood test, biopsy, genetic tests, and others.

Cancer Stage

  • STAGE I
  • STAGE II
  • STAGE III
  • STAGE IV

On the basis of cancer stage, the Middle East and Africa kidney cancer diagnostics market is segmented into stage I, stage II, stage III and stage IV.

Tumor Type

  • RENAL CELL CARCINOMA
  • CLEAR CELL RENAL CELL CARCINOMA
  • NON-CLEAR CELL RENAL CELL CARCINOMA

On the basis of tumor type, the Middle East and Africa kidney cancer diagnostics market is segmented into renal cell carcinoma, Clear cell renal cell carcinoma, and non-clear cell renal cell carcinoma.

Product

  • PLATFORM BASED PRODUCTS
  • INSTRUMENT BASED PRODUCTS
  • KITS AND REAGENTS
  • OTHER CONSUMABLES

On the basis of product, the Middle East and Africa kidney cancer diagnostics market is segmented into instrument-based products, platform-based products, kits and reagents, and other consumables.

Technology

  • FLUORESCENT IN SITU HYBRIDIZATION
  • NEXT GENERATION SEQUENCING
  • FLUOROIMMUNOASSAY
  • COMPARATIVE GENOMIC HYBRIDIZATION
  • IMMUNOHISTOCHEMICAL
  • OTHERS

On the basis of technology, the Middle East and Africa kidney cancer diagnostics market is segmented into fluorescent in situ hybridization, next-generation sequencing, fluorimmunoassay, comparative genomic hybridization, immunohistochemical, and others.

Application

  • SCREENING
  • DIAGNOSTIC AND PREDICTIVE
  • PROGNOSTIC
  • RESEARCH

On the basis of application, the Middle East and Africa kidney cancer diagnostics market is segmented into screening, diagnostic and predictive, prognostic, and research.

End User

  • HOSPITALS
  • CANCER RESEARCH CENTERS
  • ACADEMIC INSTITUTES
  • DIAGNOSTIC CENTERS
  • AMBULATORY SURGICAL CENTERS
  • OTHERS

Key Advantages of the Report: 

  • This study provides an analytical overview of the industry, including current trends and future predictions to identify potential investment opportunities.
  • The report offers insights into key drivers, limitations, and prospects, along with a comprehensive market share analysis.
  • The report quantitatively assesses the current market, shedding light on its growth prospects.
  • A Porter’s five forces analysis gauges the bargaining power of buyers and suppliers in the market.
  • The report delivers an in-depth market analysis that considers competitive dynamics and forecasts the future competitive landscape.

What to Anticipate from the Report – A 7-Point Guide:

  • The report delves into the holistic strategy and innovation within the market ecosystem.
  • It highlights prominent market drivers and obstacles, providing clarity on technological standardization and regulatory frameworks.
  • The report evaluates various implementation models and examines numerous use cases.
  • Serving as a valuable resource, the report offers essential industry insights, showcasing information on new investments, stakeholders, relevant contributors, and market participants.
  • Through the forecast period, the report conducts a thorough market analysis, referencing historical developments, ongoing events, and future growth prospects.

Top DBMR Healthcare Reports:         

Aesthetic/Cosmetic Lasers Market – Industry Trends and Forecast

Pharmaceutical Laboratory Information Management Systems Market – Industry Trends and Forecast

Automated Sample Storage Systems Market – Industry Trends and Forecast

Glaucoma Market – Industry Trends and Forecast

Clinical Trials Market – Industry Trends and Forecast

Esthetic Dental Restoration Products Market – Industry Trends and Forecast

Fractional Laser Market – Industry Trends and Forecast

Microbubble Contrast Media Market – Industry Trends and Forecast

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475

Email:- corporatesales@databridgemarketresearch.com

CDN Newswire